diaziquone has been researched along with Anaplastic Oligodendroglioma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dowling, S; Gaspar, L; Halperin, EC; Herndon, J; Imperato, J; Salter, M | 1 |
| Al Sarraf, M; Austin, D; Decker, DA; Kresge, C; Wilner, HI | 1 |
| Cairncross, JG; Macdonald, DR | 1 |
1 trial(s) available for diaziquone and Anaplastic Oligodendroglioma
| Article | Year |
|---|---|
An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium.
Topics: Adult; Aged; Aged, 80 and over; Astrocytoma; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Chemotherapy, Adjuvant; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Oligodendroglioma; Radiography; Radiotherapy Dosage; Survival Analysis | 1993 |
2 other study(ies) available for diaziquone and Anaplastic Oligodendroglioma
| Article | Year |
|---|---|
Phase II study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation. Preliminary report.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Astrocytoma; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Evaluation; Female; Follow-Up Studies; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma | 1985 |
Successful chemotherapy for recurrent malignant oligodendroglioma.
Topics: Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Female; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Vincristine | 1988 |